Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra to Prevent Inflammatory Disease in Preterm Infants
NCT05280340Phase 2Active, not recruiting
- Sponsor
- Monash Medical Centre
- Start
- Feb 2022
- Primary completion
- Mar 2024
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 2 trial of anakinra in inflammation, sponsored by Monash Medical Centre. Started Feb 2022; status: active, not recruiting.
02
Drugs
anakinra
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT05280340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05280340.